Free Trial

Hinge Health (NYSE:HNGE) Shares Gap Up - Here's Why

Hinge Health logo with Medical background

Shares of Hinge Health Inc. (NYSE:HNGE - Get Free Report) gapped up before the market opened on Friday . The stock had previously closed at $44.14, but opened at $47.00. Hinge Health shares last traded at $46.31, with a volume of 420,511 shares traded.

Analyst Upgrades and Downgrades

HNGE has been the subject of a number of research analyst reports. Bank of America initiated coverage on shares of Hinge Health in a research report on Monday, June 16th. They set a "buy" rating and a $42.00 price objective for the company. Evercore ISI initiated coverage on shares of Hinge Health in a research report on Monday, June 16th. They set an "outperform" rating and a $50.00 price objective for the company. Barclays initiated coverage on shares of Hinge Health in a research report on Monday, June 16th. They set an "overweight" rating and a $43.00 price objective for the company. Morgan Stanley initiated coverage on shares of Hinge Health in a research report on Monday, June 16th. They issued an "overweight" rating and a $46.00 price target for the company. Finally, KeyCorp began coverage on shares of Hinge Health in a research report on Monday, June 16th. They issued an "overweight" rating and a $45.00 price target for the company. One research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $46.00.

View Our Latest Analysis on HNGE

Hinge Health Stock Up 5.9%

About Hinge Health

(Get Free Report)

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Hinge Health Right Now?

Before you consider Hinge Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hinge Health wasn't on the list.

While Hinge Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines